Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 5226-5235

  Lugade, Amit A ^a   Bogner, Paul N ^a   Thatcher, Thomas H ^b   Sime, Patricia J ^b,c   Phipps, Richard P ^b,c   Thanavala, Yasmin ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 17; INTERLEUKIN 4; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; PROTEIN ANTIBODY; PROTEIN P6; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL SPECIFICITY; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; GENE REARRANGEMENT; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; IMMUNE DEFICIENCY; INFLAMMATION; MOUSE; NEUTROPHILIC INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; BACTERIAL OUTER MEMBRANE PROTEINS; CHRONIC DISEASE; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; PNEUMONIA, BACTERIAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84901276043     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302584     Document Type: Article

References (50)

1. Hogg, J. C. 2004. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364: 709-721.
2. Hogg, J. C., F. Chu, S. Utokaparch, R. Woods, W. M. Elliott, L. Buzatu, R. M. Cherniack, R. M. Rogers, F. C. Sciurba, H. O. Coxson, and P. D. Paré. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350: 2645-2653.
3. Carolan, B. J., and E. R. Sutherland. 2013. Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances. J. Allergy Clin. Immunol. 131: 627-634, quiz 635.
4. Spencer, P., and B. Krieger. 2013. The differentiation of chronic obstructive pulmonary disease from asthma: a review of current diagnostic and treatment recommendations. Open. Nurs. J. 7: 29-34.
5. Eisner, M. D., J. Balmes, P. P. Katz, L. Trupin, E. H. Yelin, and P. D. Blanc. 2005. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ. Health 4: 7.
6. Stämpfli, M. R., and G. P. Anderson. 2009. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat. Rev. Immunol. 9: 377-384.
7. John, G., K. Kohse, J. Orasche, A. Reda, J. Schnelle-Kreis, R. Zimmermann, O. Schmid, O. Eickelberg, and A. O. Yildirim. 2014. The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models. Clin. Sci. (Lond). 126: 207-221.
8. World Health Organization. 2013. World Health Statistics 2012. WHO Press, Geneva.
9. Sullivan, S. D., S. D. Ramsey, and T. A. Lee. 2000. The economic burden of COPD. Chest 117(2Suppl): 5S-9S.
10. Murphy, T. F. 2003. Respiratory infections caused by non-typeable Haemophilus influenzae. Curr. Opin. Infect. Dis. 16: 129-134.
11. Murphy, T. F. 2006. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr. Opin. Infect. Dis. 19: 225-230.
12. Soler, N., A. Torres, S. Ewig, J. Gonzalez, R. Celis, M. El-Ebiary, C. Hernandez, and R. Rodriguez-Roisin. 1998. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am. J. Respir. Crit. Care Med. 157: 1498-1505.
13. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14: 336-363.
14. Sethi, S., N. Evans, B. J. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347: 465-471.
15. Sethi, S., and T. F. Murphy. 2008. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359: 2355-2365.
16. Suissa, S., S. Dell'Aniello, and P. Ernst. 2012. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 67: 957-963.
17. Ostberg, K. L., M.W. Russell, and T. F. Murphy. 2009. Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae. Mucosal Immunol. 2: 63-73.
18. Novotny, L. A., J. D. Clements, and L. O. Bakaletz. 2013. Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization. Vaccine 31: 3417-3426.
19. Hong, W., D. Peng, M. Rivera, and X. X. Gu. 2010. Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models. Microbes Infect. 12: 11-18.
20. Murphy, T. F., C. Kirkham, and A. J. Lesse. 2006. Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae. Infect. Immun. 74: 5169-5176.
21. McMahon, M., T. F. Murphy, J. Kyd, and Y. Thanavala. 2005. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity. Vaccine 23: 3590-3596.
22. Ishida, Y., Y. Abe, M. Yanai, H. Kobayashi, and Y. Harabuchi. 2006. Identification of human T-cell epitopes and highly immunogenic analog peptides on the non-typeable Haemophilus influenzae P6 outer membrane protein. Clin. Immunol. 121: 90-99.
23. Nomura, Y., Y. Abe, Y. Ishida, H. Kobayashi, and Y. Harabuchi. 2008. Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein. J. Clin. Immunol. 28: 361-369.
24. Abe, Y., T. F. Murphy, S. Sethi, H. S. Faden, J. Dmochowski, Y. Harabuchi, and Y. M. Thanavala. 2002. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165: 967-971.
25. Badr, W. H., D. Loghmanee, R. J. Karalus, T. F. Murphy, and Y. Thanavala. 1999. Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses. Vaccine 18: 29-37.
26. Lugade, A. A., A. Bianchi-Smiraglia, V. Pradhan, G. Elkin, T. F. Murphy, and Y. Thanavala. 2011. Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling. PLoS ONE 6: e19781.
27. Herr, C., C. Beisswenger, C. Hess, K. Kandler, N. Suttorp, T. Welte, J. M. Schroeder, and C. Vogelmeier; R Bals for the CAPNETZ Study Group. 2009. Suppression of pulmonary innate host defence in smokers. Thorax 64: 144-149.
28. Thatcher, T. H., R. P. Benson, R. P. Phipps, and P. J. Sime. 2008. High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L412-L421.
29. Wu, W., K. B. Patel, J. L. Booth, W. Zhang, and J. P. Metcalf. 2011. Cigarette smoke extract suppresses the RIG-I-initiated innate immune response to influenza virus in the human lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L821-L830.
30. Marsland, B. J., M. Königshoff, S. Saglani, and O. Eickelberg. 2011. Immune system dysregulation in chronic lung disease. Eur. Respir. J. 38: 500-501.
31. Heijink, I. H., H. G. de Bruin, M. van den Berge, L. J. Bennink, S. M. Brandenburg, R. Gosens, A. J. van Oosterhout, and D. S. Postma. 2013. Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease. Thorax 68: 709-716.
32. Thatcher, T. H., S. B. Maggirwar, C. J. Baglole, H. F. Lakatos, T. A. Gasiewicz, R. P. Phipps, and P. J. Sime. 2007. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am. J. Pathol. 170: 855-864.
33. Thatcher, T. H., H. M. Hsiao, E. Pinner, M. Laudon, S. J. Pollock, P. J. Sime, and R. P. Phipps. 2013. Neu-164 and Neu-107, two novel antioxidant and antimyeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 305: L165-L174.
34. Lugade, A. A., P. N. Bogner, and Y. Thanavala. 2011. Murine model of chronic respiratory inflammation. Adv. Exp. Med. Biol. 780: 125-141.
35. Gaschler, G. J., M. Skrtic, C. C. Zavitz, M. Lindahl, P. O. Onnervik, T. F. Murphy, S. Sethi, and M. R. Stämpfli. 2009. Bacteria challenge in smokeexposed mice exacerbates inflammation and skews the inflammatory profile. Am. J. Respir. Crit. Care Med. 179: 666-675.
36. van Rijt, S. H., I. E. Keller, G. John, K. Kohse, A. O. Yildirim, O. Eickelberg, and S. Meiners. 2012. Acute cigarette smoke exposure impairs proteasome function in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 303: L814-L823.
37. Miossec, P., and J. K. Kolls. 2012. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11: 763-776.
38. Zheng, Y., D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23- induced dermal inflammation and acanthosis. Nature 445: 648-651.
39. Ramirez-Velazquez, C., E. C. Castillo, L. Guido-Bayardo, and V. Ortiz-Navarrete. 2013. IL-17-producing peripheral blood CD177+ neutrophils increase in allergic asthmatic subjects. Allergy Asthma Clin. Immunol. 9: 23.
40. Zhang, J., S. Chu, X. Zhong, Q. Lao, Z. He, and Y. Liang. 2013. Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers. Int. Immunopharmacol. 15: 58-66.
41. Wang, H., W. Peng, Y. Weng, H. Ying, H. Li, D. Xia, and W. Yu. 2012. Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure. Int. Immunopharmacol. 14: 504-512.
42. Martey, C. A., C. J. Baglole, T. A. Gasiewicz, P. J. Sime, and R. P. Phipps. 2005. The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L391-L399.
43. Chen, K., D. A. Pociask, J. P. McAleer, Y. R. Chan, J. F. Alcorn, J. L. Kreindler, M. R. Keyser, S. D. Shapiro, A. M. Houghton, J. K. Kolls, and M. Zheng. 2011. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS ONE 6: e20333.
44. La Flamme, A.C.,M. Kharkrang, S. Stone, S. Mirmoeini, D. Chuluundorj, and R. Kyle. 2012. Type II-activated murine macrophages produce IL-4. PLoS ONE 7: e46989.
45. Xu, Y., H. Li, B. Bajrami, H. Kwak, S. Cao, P. Liu, J. Zhou, Y. Zhou, H. Zhu, K. Ye, and H. R. Luo. 2013. Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate. Proc. Natl. Acad. Sci. USA 110: 7726-7731.
46. Berenson, C. S., M. A. Garlipp, L. J. Grove, J. Maloney, and S. Sethi. 2006. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J. Infect. Dis. 194: 1375-1384.
47. Droemann, D., T. Goldmann, T. Tiedje, P. Zabel, K. Dalhoff, and B. Schaaf. 2005. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir. Res. 6: 68.
48. Lugade, A. A., P. N. Bogner, T. F. Murphy, and Y. Thanavala. 2011. The role of TLR2 and bacterial lipoprotein in enhancing airway inflammation and immunity. Front. Immunol. 2: 10.
49. Roche, N., R.Marthan, P. Berger, A. Chambellan, P. Chanez, B. Aguilaniu, P. Y. Brillet, P. R. Burgel, A. Chaouat, P. Devillier, et al. 2011. Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur. Respir. Rev. 20: 175-182.
50. Ernst, P., A. V. Gonzalez, P. Brassard, and S. Suissa. 2007. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am. J. Respir. Crit. Care Med. 176: 162-166.